Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

UFS awarded R3,6-million to train court interpreters
2008-05-15

 
 At the training session for court interpreters that took place on the Main Campus of the UFS in Bloemfontein recently are, from the left, front: Ms Zandile Mtolo, Pietermaritzburg, Ms Lindiwe Gamede, Bethlehem; back: Mr Sipho Majombozi, Port Shepstone, Prof. Lotriet, and Mr Mzi Nombewu, Upington. The four learners are working at their respective magistrates courts.
Photo: Lacea Loader

UFS awarded R3,6-million to train court interpreters

A contract to the value of R3,6-million has been awarded to the University of the Free State (UFS) to train court interpreters throughout South Africa.

The contract was awarded to the Department of Afro-asiatic Studies, Sign Language and Language Practice at the UFS by the Safety and Security Sector Education and Training Authority (SASSETA).

“We are the only tertiary institution in the country that offers a national diploma in court interpreting. It provides a unique opportunity to court interpreters to be trained by a group of eight lecturers who are experts in the field,” says Prof. Annelie Lotriet, associate professor at the Department of Afro-asiatic Studies, Sign Language and Language Practice.

Prof. Lotriet is an internationally renowned interpreting expert who was also responsible for the training of interpreters for the former Truth and Reconciliation Commission.

According to Prof. Lotriet no co-ordinated training programmes for court interpreters existed and there was also no control over the training processes. The programme, initiated by the Department of Justice and Constitutional Development, is managed by the SASSETA. “It is the first time that the Department of Justice and Constitutional Development initiates such an extensive training programme for court interpreters,” says Prof. Lotriet.

The group of 100 court interpreters on the programme are from all over the country. Of the group, ten are unemployed learners who interpret for the Department of Justice and Constitutional Development on an ad-hoc basis.

The programme, which stretches over two years, comprises of theoretical and service training. Contact sessions take place in Bloemfontein, Pretoria and Cape Town, four times a year for two weeks at a time. The second contact session for Bloemfontein was recently completed.

“Learners are nominated by their regional offices. The programme consists of interpreting theory, interpreting practice and basic law subjects. The training material is developed and written by the SASSETA and facilitated and presented by the UFS. The learners interpret in all the 11 languages. Some of them can speak a couple of languages each,” says Prof. Lotriet.

“Everything is going very well with the programme and we are receiving a lot of positive feedback from the learners. This first group is an experiment and it depends on their success whether the Department of Justice and Constitutional Development will expand the programme,” says Prof. Lotriet.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za
15 May 2008 
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept